Atzema Clare L, Austin Peter C
Department of Trauma, Emergency and Critical Care, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Acad Emerg Med. 2017 Nov;24(11):1334-1348. doi: 10.1111/acem.13303.
Rate control is an important component of the management of patients with atrial fibrillation (AF). Previous studies of emergency department (ED) rate control have been limited by relatively small sample sizes. We examined the use of beta-blockers (BBs) versus nondihydropyridine calcium channel blockers (CCBs) in ED patients from 24 sites and the associated hospital admission rates.
In this preplanned substudy, we examined chart data on AF patients who visited one of 24 hospital EDs in Ontario, Canada, between April 2008 and March 2009. We describe the proportion of patients who received either a BB or a CCB, had a heart rate < 110 beats/min 2 hours later, and had any complications. We used hierarchical logistic regression modeling to determine the predictors of BB versus CCB use and to assess the between-hospital variation in use of BBs versus CCBs. Solely in patients who had no rhythm control attempts, we examined the difference in the probability of hospital admission after propensity score matching patients by medication class.
Of the 1,639 patients who received either a BB (n = 429) or a CCB (n = 1,210), 70.9% of the patients who received a BB had successful rate control versus 66.1% for a CCB. Complications were rare (2.4%), and the large majority were hypotension (2.0%). In adjusted analyses, predictors of receiving a BB (compared to a CCB) included already being on a BB, being sent in from a doctor's office, or being seen at a teaching hospital. In contrast, patients with evidence of heart failure, prior use of a CCB, a higher presenting heart rate, or a successful pharmacologic cardioversion (vs. no attempt) or who were seen at the highest AF volume EDs were significantly less likely to receive a BB, compared to a CCB. Systematic between-hospital differences accounted for 8% of the variation in BB versus CCB use. Hospital characteristics accounted for the large majority of that variation: after accounting for patient characteristics the between-hospital variation decreased by a relative 2.8%. By further adjusting for hospital characteristics, it decreased by a relative 74.7%. Among propensity score-matched patients with no rhythm control attempts, more CCB patients were admitted (51.6%) compared to BB patients (40.0%; difference of 11.6%; 95% confidence interval = 7.9%-16.2%).
In this study of 24 EDs, CCBs were used more frequently for rate control than BBs, and complications were rare and easily managed using both agents. Variation between hospitals in BB versus CCB use was predominantly due to hospital characteristics such as teaching status and AF volumes, rather than different case mix. Among patients who did not receive attempts at rhythm control, use of a BB for rate control was associated with a lower rate of hospitalization.
心率控制是心房颤动(AF)患者管理的重要组成部分。既往急诊科(ED)心率控制研究因样本量相对较小而受到限制。我们研究了24个地点的ED患者中β受体阻滞剂(BBs)与非二氢吡啶类钙通道阻滞剂(CCBs)的使用情况以及相关的住院率。
在这项预先计划的子研究中,我们检查了2008年4月至2009年3月期间在加拿大安大略省24家医院急诊科就诊的AF患者的病历数据。我们描述了接受BB或CCB治疗、2小时后心率<1每分钟10次且有任何并发症的患者比例。我们使用分层逻辑回归模型来确定使用BB与CCB的预测因素,并评估医院间使用BB与CCB的差异。仅在未尝试节律控制的患者中,我们通过倾向评分匹配药物类别后,检查了住院概率的差异。
在1639例接受BB(n = 429)或CCB(n = 1210)治疗的患者中,接受BB治疗的患者70.9%心率控制成功,而接受CCB治疗的患者为66.1%。并发症很少见(2.4%),绝大多数是低血压(2.0%)。在调整分析中,接受BB(与CCB相比)的预测因素包括已在使用BB、从医生办公室送来或在教学医院就诊。相比之下,有心力衰竭证据、既往使用过CCB、就诊时心率较高、成功进行药物复律(与未尝试相比)或在房颤就诊量最高的急诊科就诊的患者,与接受CCB相比,接受BB的可能性显著降低。医院间的系统差异占BB与CCB使用差异的8%。医院特征占该差异的大部分:在考虑患者特征后,医院间差异相对降低了2.8%。通过进一步调整医院特征,差异相对降低了74.7%。在倾向评分匹配且未尝试节律控制的患者中,CCB治疗的患者住院率更高(51.6%),而BB治疗的患者为40.0%(差异为11.6%;95%置信区间 = 7.9%-16.2%)。
在这项对24家急诊科的研究中,CCB用于心率控制的频率高于BB,并发症很少见,且两种药物都易于处理。医院间BB与CCB使用的差异主要归因于医院特征,如教学状况和房颤就诊量,而非不同的病例组合。在未接受节律控制尝试的患者中,使用BB进行心率控制与较低的住院率相关。